Compare MRK & HSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRK | HSBC |
|---|---|---|
| Founded | 2000 | 1865 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | 304.0B |
| IPO Year | 1994 | N/A |
| Metric | MRK | HSBC |
|---|---|---|
| Price | $112.09 | $92.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 3 |
| Target Price | ★ $125.59 | N/A |
| AVG Volume (30 Days) | ★ 7.6M | 1.6M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | 3.06% | ★ 4.18% |
| EPS Growth | ★ 8.01 | N/A |
| EPS | ★ 7.28 | N/A |
| Revenue | ★ $65,011,000,000.00 | N/A |
| Revenue This Year | $3.61 | $14.95 |
| Revenue Next Year | $5.41 | $3.66 |
| P/E Ratio | ★ $15.03 | $94.79 |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $75.40 | $56.21 |
| 52 Week High | $125.14 | $94.80 |
| Indicator | MRK | HSBC |
|---|---|---|
| Relative Strength Index (RSI) | 43.28 | 63.94 |
| Support Level | $105.23 | $88.64 |
| Resistance Level | $112.44 | $92.98 |
| Average True Range (ATR) | 2.90 | 1.19 |
| MACD | -0.69 | -0.08 |
| Stochastic Oscillator | 34.39 | 82.14 |
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Established in 1865 in Hong Kong, London-based HSBC is one of the largest banks in the world, with assets of USD 3 trillion and over 40 million customers worldwide. It operates in more than 50 countries with more than 200,000 full-time staff. The United Kingdom and Hong Kong are its two largest markets. The bank offers retail, commercial and institutional banking, global banking and markets, wealth management, and private banking.